UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K/A
(Amendment No. 1)
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 5, 2014
___________________
CareFusion Corporation
(Exact Name of Registrant as Specified in its Charter)
___________________
Delaware
(State or Other Jurisdiction of Incorporation)
001-34273 | 26-4123274 | |
(Commission File Number) | (IRS Employer Identification Number) | |
3750 Torrey View Court, San Diego, California 92130
(Address of Principal Executive Offices, Including Zip Code)
(858) 617-2000
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or Former Address, If Changed Since Last Report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On May 7, 2014, CareFusion Corporation (the “Company”) filed a Current Report on Form 8-K in which it announced that the Board of Directors of the Company (the “Board”) had elected Mr. Supratim Bose as a director of the Company, effective May 7, 2014. At the time of his election, Mr. Bose was not appointed to serve on a Board committee. The Company is filing this Form 8-K/A to report that on November 5, 2014, Mr. Bose was appointed to serve as a member of the Governance and Compliance Committee of the Board. As of November 5, 2014, the members of the Governance and Compliance Committee were Dr. Edward D. Miller, Mr. Philip L. Francis and Mr. Supratim Bose.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CareFusion Corporation | ||||||
(Registrant) | ||||||
Date: November 5, 2014 | By: | /s/ Joan Stafslien | ||||
Name: | Joan Stafslien | |||||
Title: | Executive Vice President, General Counsel and Corporate Secretary | |||||